Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 12 | |
Hold | 4 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 17 analysts offering 12 month price targets for Cytokinetics, Inc. have a median target of 80.00, with a high estimate of 120.00 and a low estimate of 60.00. The median estimate represents a 67.82% increase from the last price of 47.67.
High | 151.7% | 120.00 |
Med | 67.8% | 80.00 |
Low | 25.9% | 60.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | -0.23% |
Average growth rate | -29.00% |
More ▼
Revenue history & estimates in USD
Average growth rate | +77.01% |
Average growth rate | +19.05% |
More ▼